pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-412 |
Genomic Coordinates | chr14: 101065447 - 101065537 |
Synonyms | MIRN412, hsa-mir-412, MIR412 |
Description | Homo sapiens miR-412 stem-loop |
Comment | None |
RNA Secondary Structure | ![]() |
Mature miRNA Information | ||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-412-3p | |||||||||||||||||||||||||||||||||||||||
Sequence | 54| ACUUCACCUGGUCCACUAGCCGU |76 | |||||||||||||||||||||||||||||||||||||||
Evidence | Not_experimental | |||||||||||||||||||||||||||||||||||||||
Experiments | DRVs in miRNA |
|
||||||||||||||||||||||||||||||||||||||
SNPs in miRNA |
|
|||||||||||||||||||||||||||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
miRNAs in Extracellular Vesicles |
|
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | ZNF701 | ||||||||||||||||||||
Synonyms | - | ||||||||||||||||||||
Description | zinc finger protein 701 | ||||||||||||||||||||
Transcript | NM_001172655 | ||||||||||||||||||||
Other Transcripts | NM_018260 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on ZNF701 | |||||||||||||||||||||
3'UTR of ZNF701 (miRNA target sites are highlighted) |
>ZNF701|NM_001172655|3'UTR 1 AAGTGTAAATTTGCAAGGTTTTTAGGCAACAGTCAAACCTTGCATGTCATCATAGACTTTATACTGGAGAGAAACCTTAC 81 AAATGTGAAGAATGTGACAAAAGTTTTCAATTTCAAATCACTCCTTGAAATACATAGGAGAGTTCATACTGGAGAGAAAC 161 CATACAAATGTAAGGTTTGTGACAAGGATTTCGGGTGTGATTCACACCTGGCCCAACATACTGGAATTCACACTGGAAAG 241 GAACTGTACAAGTGTAATGAGTGTGGCAGAGCCTTTGGTGGTCAGTCAACACTTACTCACCATCAAGCAATCCATGGTAT 321 AGGGAAACTTGACTAATGTAATGATTGTCACAAAGTCTTCAGTAATATTACAGCCATTGCAAAACATTGGAGAATCCATA 401 ATGAAGGAGGTCTTACAAGTGTAATAAATGTGGCAAGTTTTTCAGACATCATTCATAACTTGCAGTTCATTGGCGATCTT 481 ATACAGGAGAGAAATCTTACAAATGTGATGATTGTGGCAAGGTCTTCAGTCAAGCTTCATCTTTTGCAAAACGGGAGAAT 561 TCATACAGGAGAGAAACCTCACAAGTGTGATGATTGTGAGCAAAGCCTTTACTTCACGTTCACACCACATTAGATATCAG 641 AGGATCCATACTGGACAGAAATCTTACAAACGTCCTATGTGTGGCAAGGTCTTCAGTCCGAGGTTACTCCTTGCAGAATA 721 TCATAACGTTCATTTTTGAGGTAATAGTTACAAATGCGGTGAGCACAGCAAACCATCAAGGATTGACAGTAGAGTCAATT 801 CAGAATTGACTTGAGTTTGAGTTGACTTAAAACATTCAGTTGAAGCATTAATTGACATTAAAGTGTTTATGTTAAGAGGA 881 TTGGGCCAGGCGTGTGGCTCACGCCTGTAAATCCAGCACTTTAGGAGCCCAAGGTGGATAGATCACTTGAGGTCATGAGT 961 TTGAGATCAGCCTGGCCAACAGACGTGAGTCACTTTTCCCAGCCTGCTTTTTGTTTCTTTAACAAAAACCAATAGGGGTT 1041 TTTATAGGTATTGTGTTGAATCTGAATCACATTGGCTTATATAATAACAATATTGATTTTTCCAAACCATCAATGTGGGT 1121 TGTATATATATGTTTTTAATCATTTTGGTTAATGTTTGTAGATTTCAAGGTGTGAAATTCTCAGTTTTTTTATGTTTATT 1201 CCTAAGTATTTCTTACTTTAAGATCTCTAGCAAATGGAAGTGTTTTTTAATTTTCGTTTAAATTTTTTATTGTTTATGGA 1281 AATTCAATTAATTTTTGGTGCTGCTATTGCATTGTGCAAATCCACTGAATGTGTTGATTAGTTCCAGTAGTATTTTGGTT 1361 GACTCAGGCCCCGCCCACCTCTTCGCCTCCCGTCTGGCCTGACCCAGGCCCCGCCCACCTCCTCGGGGGTCTCCCCGCGG 1441 GTCTGGCTTCTGTACTGTGCTGATTGGCACAGACCCGGAAGCTGATGGCATGGACTGAAGGTTGCCCCGTTGAGTTTGCG 1521 CTTCCCAGTTCTCTGGTACTGCTATACCGGGGACGTGGGTGTCTCCACAGACCTGGAAATTCCGGCCCCTCTTTCTCAAC 1601 TCAGAGCAAATTGAGACGTCCGGGTGGGAGTCCGTGAGTCTTTTCCTTTTGAGTTTAAAGTCGCCCTGAGGCTGGTCCCG 1681 TCCCGGTCTTTTCTGCAGTAGGGCCGTGCAGACACCTCCTGTAGCGAAACTTTCCTTCTCAAAACCCTTCCCGACCCGTC 1761 CTCCCGCCTCGCGCTGTTTCAGGTCCTCACCAGCGAGTTGGACTCTCGCCCTGGGCTCCTCATCGGCGCCTGGAGGGCAG 1841 CGCTGCAGCCCCACTCCCGGGAAGGCCGCGTCCTCTGCCTGGTCCTGGGATCCTGCAGACCCCACCCCTGTCCGAAGGCG 1921 CCATCGCCCACCACCTCCCTCCTCGTGCCGGCCCTGCTTCTCCCCAGTTCCAACCCCAGGAAAACGTGCTTCTCCTGGAG 2001 GCAACCCTCTTTTTCCACCCTCGCCCTGTTGTTCCCGGAAGGCAGGCCTGGAATGTGAAGTTTCCAGGTAGATGGATATT 2081 AAACATAGAATTGAAGAAAAAAAAAAAAACCCCACAAAGTAACAAAAGAATGAAGCGGCGAAAGCAGAAATTTACTCAAC 2161 CAAGAAAGCACCCCACAGGGTGGGGGTGGGCCCAAGCGAGCGTCTCCAGGGCCCCATTTACAAAGTTTTTGGAGGTTATT 2241 TTTTTTTGAGGTCCCTATGGGCTACCCCTTATCTGGATGAAGAATTTGGCCCTTGGCCAAGGAAATAACTGAGGTAAATT 2321 GGCCTGAGGCCAGAGCAGATGGGTGCCCTATGCAGATGAAGGGGTGGCCGGTGCTTGGCCTTGGCCACTCCTGGGCTCTT 2401 TCTCTTTCCACCTGCGACCTGGTGGAAGGGGGAGGGTGTTAGGGAGAGTAGCCTTTGATCCTTTGTTACTTTGGGTGGGA 2481 AGATGGGGTTTTTCCTTTTAGTCTAGTTTTGGAAAGTTCGCGTTAATTGGTTTTAGATTCCCTGCCTCCCTAGACCCAGG 2561 ACCCATGTGGTTTTTTTTGTTTTTGTTTTTGTTTTTTTGATGGAGATGGGGTCTTACTCTGCTGCGCAGGCCGAAGAGCG 2641 GTGACCGGATCACAGCTCACTGCAGCTTCAACCTCCTGGGCTCAAGGGATCCTCCCACCTCAGCCTGCAGAGTAGCTGGG 2721 ACCACAGCCGCGCGCCACCACACCGCGCCAATTTTTGTGTTCTTGGTAGAGACCGGGTTTTGCCTTGTTGTCTAGGTTGG 2801 GCTCCAACTGCAGGGCTAAAGCGATCCAAGAGCATCAGCCTCCCAAAGTGCTGGGATTACAGGCTTGAGCCACCATGCCC 2881 GCCTTATTTCTTAATTTAAAAAAAAAAATGTATATGTAGACTGAACGCGGTGGCTCATGCCTGTCATCCCAGCACTTTGT 2961 GAGGCCGATTCTCCTCTATCCAGGAGACGGGTTTCACCATTTTGCCAGGTTTGTCTCAAACTCCTCGGCTTAACTGATCC 3041 GCTTGCTTTGGCCTTCCAAAGTGCTAGGATTACAGGAGTGAGCCACCACACGTAGCCAGTCCTGGCATTTTGTAGAAGGA 3121 TGGCCAACGCAGCCTGTTGACCCTTCCTGGCCATCACATGAAAATCAGCGACTCTTCCTTCTTACAAAACTCGGAGCTTC 3201 TCAGGATAACTTGGTGAAACGTCCCCCGCTGTGAACCTCAGTGAGCCCACCTGTAATATACAGGTGAGGGAGAAGACCAG 3281 AAAAGCTCAGTCAGAGTGACACTGACCCCTGAAATGATGGGCACAATGGAGTGTGTGGCTTTTCCTGTAGGACAGGGAGG 3361 TATTTAGTTGTAGTTTGAACTTTAAAGGATTCCAGTCCTCCGAAAAACAGGATTAGACTCAAATCACCTTGAACCTTATC 3441 ATCTCATGGCTTTGACCCACCTACATGGCTCCGTGTCCCCTGCAGGCCTCGCCCCGGAGCTCTACAATCCTGTGTGCAGT 3521 TGTCTCCGCAGCTCTCTGCTGGGACATCAAACAGGCATCTCCACCTTCATGTGTCTATAAGTGACTTCCTAAACCCCCAA 3601 ACACATTCCCTTACAGTCCTACACATCTCAGATGAGGGTGACAGTGTACTTCTGGGTGCTTAGCTGAGGTTGACACCATG 3681 TATTTTAAATATGGAAAATAAATTACATTATTTGTAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | Hela | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
HITS-CLIP data was present in GSM1048187. RNA binding protein: AGO2. Condition:Hela_AGO2_CLIP_control
HITS-CLIP data was present in GSM1048188. RNA binding protein: AGO2. Condition:Hela_AGO2_CLIP_ptb_knockdown
... - Xue Y; Ouyang K; Huang J; Zhou Y; Ouyang H; et al., 2013, Cell. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Xue Y; Ouyang K; Huang J; Zhou Y; Ouyang H; et al. - Cell, 2013
The induction of pluripotency or trans-differentiation of one cell type to another can be accomplished with cell-lineage-specific transcription factors. Here, we report that repression of a single RNA binding polypyrimidine-tract-binding (PTB) protein, which occurs during normal brain development via the action of miR-124, is sufficient to induce trans-differentiation of fibroblasts into functional neurons. Besides its traditional role in regulated splicing, we show that PTB has a previously undocumented function in the regulation of microRNA functions, suppressing or enhancing microRNA targeting by competitive binding on target mRNA or altering local RNA secondary structure. A key event during neuronal induction is the relief of PTB-mediated blockage of microRNA action on multiple components of the REST complex, thereby derepressing a large array of neuronal genes, including miR-124 and multiple neuronal-specific transcription factors, in nonneuronal cells. This converts a negative feedback loop to a positive one to elicit cellular reprogramming to the neuronal lineage.
LinkOut: [PMID: 23313552]
|
Experimental Support 2 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | HEK293 |
Disease | 55762.0 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
"PAR-CLIP data was present in GSM1065667. RNA binding protein: AGO1. Condition:4-thiouridine
... - Memczak S; Jens M; Elefsinioti A; Torti F; et al., 2013, Nature. |
Article |
- Memczak S; Jens M; Elefsinioti A; Torti F; et al. - Nature, 2013
Circular RNAs (circRNAs) in animals are an enigmatic class of RNA with unknown function. To explore circRNAs systematically, we sequenced and computationally analysed human, mouse and nematode RNA. We detected thousands of well-expressed, stable circRNAs, often showing tissue/developmental-stage-specific expression. Sequence analysis indicated important regulatory functions for circRNAs. We found that a human circRNA, antisense to the cerebellar degeneration-related protein 1 transcript (CDR1as), is densely bound by microRNA (miRNA) effector complexes and harbours 63 conserved binding sites for the ancient miRNA miR-7. Further analyses indicated that CDR1as functions to bind miR-7 in neuronal tissues. Human CDR1as expression in zebrafish impaired midbrain development, similar to knocking down miR-7, suggesting that CDR1as is a miRNA antagonist with a miRNA-binding capacity ten times higher than any other known transcript. Together, our data provide evidence that circRNAs form a large class of post-transcriptional regulators. Numerous circRNAs form by head-to-tail splicing of exons, suggesting previously unrecognized regulatory potential of coding sequences.
LinkOut: [PMID: 23446348]
|
CLIP-seq Support 1 for dataset GSM1048187 | |
---|---|
Method / RBP | HITS-CLIP / AGO2 |
Cell line / Condition | Hela / Hela_AGO2_CLIP_control |
Location of target site | ENST00000540331.1 | 3UTR | AUACUGGAGAGAAACCUUACAAAUGUGAAGAAUGUG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23313552 / GSE42701 |
CLIP-seq Viewer | Link |
CLIP-seq Support 2 for dataset GSM1048188 | |
---|---|
Method / RBP | HITS-CLIP / AGO2 |
Cell line / Condition | Hela / Hela_AGO2_CLIP_ptb_knockdown |
Location of target site | ENST00000540331.1 | 3UTR | UUAUACUGGAGAGAAACCUUACAAAUGUGAAGAAUGUG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23313552 / GSE42701 |
CLIP-seq Viewer | Link |
CLIP-seq Support 3 for dataset GSM1065667 | |
---|---|
Method / RBP | PAR-CLIP / AGO1 |
Cell line / Condition | HEK293 / 4-thiouridine, ML_MM_6 |
Location of target site | ENST00000540331.1 | 3UTR | ACUUUAUACUGGAGAGAAACCUUACAAAUGUGAAGAAU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23446348 / GSE43573 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
138 hsa-miR-412-3p Target Genes:
Functional analysis:
ID![]() |
Target | Description | Validation methods |
![]() |
![]() |
|||||||
Strong evidence | Less strong evidence | |||||||||||
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
|||||
MIRT005780 | ACVR1C | activin A receptor type 1C | ![]() |
1 | 1 | |||||||
MIRT062013 | YOD1 | YOD1 deubiquitinase | ![]() |
![]() |
2 | 2 | ||||||
MIRT345112 | ATXN7L3 | ataxin 7 like 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT383735 | EDEM3 | ER degradation enhancing alpha-mannosidase like protein 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT396956 | CELF1 | CUGBP Elav-like family member 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT439280 | XIAP | X-linked inhibitor of apoptosis | ![]() |
1 | 1 | |||||||
MIRT439313 | VAT1 | vesicle amine transport 1 | ![]() |
1 | 1 | |||||||
MIRT439375 | TUBA1A | tubulin alpha 1a | ![]() |
1 | 1 | |||||||
MIRT439418 | TMOD1 | tropomodulin 1 | ![]() |
1 | 1 | |||||||
MIRT439503 | SURF4 | surfeit 4 | ![]() |
1 | 1 | |||||||
MIRT439563 | SON | SON DNA binding protein | ![]() |
1 | 1 | |||||||
MIRT439598 | SLC3A2 | solute carrier family 3 member 2 | ![]() |
1 | 1 | |||||||
MIRT439670 | SETD1B | SET domain containing 1B | ![]() |
1 | 1 | |||||||
MIRT439767 | RMND5A | required for meiotic nuclear division 5 homolog A | ![]() |
1 | 1 | |||||||
MIRT439922 | PPL | periplakin | ![]() |
1 | 1 | |||||||
MIRT439947 | PLEKHA6 | pleckstrin homology domain containing A6 | ![]() |
1 | 1 | |||||||
MIRT439952 | PLCB4 | phospholipase C beta 4 | ![]() |
1 | 1 | |||||||
MIRT439961 | PKD1 | polycystin 1, transient receptor potential channel interacting | ![]() |
1 | 1 | |||||||
MIRT440005 | PEG3 | paternally expressed 3 | ![]() |
1 | 1 | |||||||
MIRT440061 | OSBPL8 | oxysterol binding protein like 8 | ![]() |
1 | 1 | |||||||
MIRT440166 | MYH14 | myosin heavy chain 14 | ![]() |
1 | 1 | |||||||
MIRT440276 | MAPK8IP1 | mitogen-activated protein kinase 8 interacting protein 1 | ![]() |
1 | 1 | |||||||
MIRT440437 | IPO13 | importin 13 | ![]() |
1 | 1 | |||||||
MIRT440441 | INTS3 | integrator complex subunit 3 | ![]() |
1 | 1 | |||||||
MIRT440448 | INS | insulin | ![]() |
1 | 1 | |||||||
MIRT440461 | IGF2R | insulin like growth factor 2 receptor | ![]() |
1 | 1 | |||||||
MIRT440472 | IARS | isoleucyl-tRNA synthetase | ![]() |
1 | 1 | |||||||
MIRT440530 | GUCY1A3 | guanylate cyclase 1 soluble subunit alpha | ![]() |
1 | 1 | |||||||
MIRT440542 | GOLGA2 | golgin A2 | ![]() |
1 | 1 | |||||||
MIRT440569 | GIGYF1 | GRB10 interacting GYF protein 1 | ![]() |
1 | 1 | |||||||
MIRT440608 | FTSJD2 | cap methyltransferase 1 | ![]() |
1 | 1 | |||||||
MIRT440750 | EEF1A2 | eukaryotic translation elongation factor 1 alpha 2 | ![]() |
1 | 1 | |||||||
MIRT440781 | DOT1L | DOT1 like histone lysine methyltransferase | ![]() |
1 | 1 | |||||||
MIRT440804 | DNAJA4 | DnaJ heat shock protein family (Hsp40) member A4 | ![]() |
1 | 1 | |||||||
MIRT440867 | CSDE1 | cold shock domain containing E1 | ![]() |
1 | 1 | |||||||
MIRT440890 | CPEB4 | cytoplasmic polyadenylation element binding protein 4 | ![]() |
1 | 1 | |||||||
MIRT440917 | COL1A1 | collagen type I alpha 1 chain | ![]() |
1 | 1 | |||||||
MIRT440967 | CDH22 | cadherin 22 | ![]() |
1 | 1 | |||||||
MIRT440968 | CDH2 | cadherin 2 | ![]() |
1 | 1 | |||||||
MIRT441024 | CALR | calreticulin | ![]() |
1 | 1 | |||||||
MIRT441278 | ACTB | actin beta | ![]() |
1 | 1 | |||||||
MIRT448421 | TNFAIP3 | TNF alpha induced protein 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT462833 | BCL3 | B-cell CLL/lymphoma 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT465062 | TSR1 | TSR1, ribosome maturation factor | ![]() |
![]() |
2 | 2 | ||||||
MIRT476050 | GRSF1 | G-rich RNA sequence binding factor 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT485318 | MZT1 | mitotic spindle organizing protein 1 | ![]() |
![]() |
2 | 4 | ||||||
MIRT493584 | HNRNPA1 | heterogeneous nuclear ribonucleoprotein A1 | ![]() |
![]() |
2 | 6 | ||||||
MIRT494567 | BAK1 | BCL2 antagonist/killer 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT497393 | RALY | RALY heterogeneous nuclear ribonucleoprotein | ![]() |
![]() |
2 | 2 | ||||||
MIRT503250 | ZNF257 | zinc finger protein 257 | ![]() |
![]() |
2 | 10 | ||||||
MIRT503656 | ZNF138 | zinc finger protein 138 | ![]() |
![]() |
2 | 10 | ||||||
MIRT505882 | RNF219 | ring finger protein 219 | ![]() |
![]() |
2 | 2 | ||||||
MIRT507525 | DSTN | destrin, actin depolymerizing factor | ![]() |
![]() |
2 | 4 | ||||||
MIRT510663 | TMBIM6 | transmembrane BAX inhibitor motif containing 6 | ![]() |
![]() |
2 | 4 | ||||||
MIRT514682 | ZNF701 | zinc finger protein 701 | ![]() |
![]() |
2 | 4 | ||||||
MIRT515370 | ZNF208 | zinc finger protein 208 | ![]() |
![]() |
2 | 6 | ||||||
MIRT525237 | KCNJ12 | potassium voltage-gated channel subfamily J member 12 | ![]() |
![]() |
2 | 2 | ||||||
MIRT527963 | MTAP | methylthioadenosine phosphorylase | ![]() |
![]() |
2 | 2 | ||||||
MIRT528482 | STAMBPL1 | STAM binding protein like 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT529909 | C1orf64 | steroid receptor associated and regulated protein | ![]() |
![]() |
2 | 4 | ||||||
MIRT531558 | SRD5A1 | steroid 5 alpha-reductase 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT532234 | KLF2 | Kruppel like factor 2 | ![]() |
![]() |
2 | 4 | ||||||
MIRT532480 | HOXA13 | homeobox A13 | ![]() |
![]() |
2 | 2 | ||||||
MIRT535544 | P2RY2 | purinergic receptor P2Y2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT547311 | NR1D2 | nuclear receptor subfamily 1 group D member 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT551795 | ZNF117 | zinc finger protein 117 | ![]() |
![]() |
2 | 4 | ||||||
MIRT554939 | RAP1A | RAP1A, member of RAS oncogene family | ![]() |
![]() |
2 | 2 | ||||||
MIRT558171 | EIF5A2 | eukaryotic translation initiation factor 5A2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT568771 | LY6K | lymphocyte antigen 6 family member K | ![]() |
![]() |
2 | 2 | ||||||
MIRT570766 | ZNF99 | zinc finger protein 99 | ![]() |
![]() |
2 | 2 | ||||||
MIRT572405 | MRPS14 | mitochondrial ribosomal protein S14 | ![]() |
![]() |
2 | 2 | ||||||
MIRT573396 | DLC1 | DLC1 Rho GTPase activating protein | ![]() |
![]() |
2 | 2 | ||||||
MIRT610403 | RXRB | retinoid X receptor beta | ![]() |
![]() |
2 | 2 | ||||||
MIRT610886 | SCN8A | sodium voltage-gated channel alpha subunit 8 | ![]() |
![]() |
2 | 2 | ||||||
MIRT611197 | TMEM105 | transmembrane protein 105 | ![]() |
![]() |
2 | 2 | ||||||
MIRT611244 | ZNF550 | zinc finger protein 550 | ![]() |
![]() |
2 | 2 | ||||||
MIRT615669 | LRIG2 | leucine rich repeats and immunoglobulin like domains 2 | ![]() |
![]() |
2 | 4 | ||||||
MIRT617974 | DOCK4 | dedicator of cytokinesis 4 | ![]() |
![]() |
2 | 2 | ||||||
MIRT619150 | ZNF326 | zinc finger protein 326 | ![]() |
![]() |
2 | 2 | ||||||
MIRT619608 | MKKS | McKusick-Kaufman syndrome | ![]() |
![]() |
2 | 2 | ||||||
MIRT621053 | DGKD | diacylglycerol kinase delta | ![]() |
![]() |
2 | 2 | ||||||
MIRT623665 | HRK | harakiri, BCL2 interacting protein | ![]() |
![]() |
2 | 2 | ||||||
MIRT624883 | AASDHPPT | aminoadipate-semialdehyde dehydrogenase-phosphopantetheinyl transferase | ![]() |
![]() |
2 | 2 | ||||||
MIRT624939 | MARCH2 | membrane associated ring-CH-type finger 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT634198 | TMOD2 | tropomodulin 2 | ![]() |
![]() |
2 | 4 | ||||||
MIRT636727 | AGO2 | argonaute 2, RISC catalytic component | ![]() |
![]() |
2 | 2 | ||||||
MIRT637741 | POLR3K | RNA polymerase III subunit K | ![]() |
![]() |
2 | 2 | ||||||
MIRT638002 | ZC3H13 | zinc finger CCCH-type containing 13 | ![]() |
![]() |
2 | 2 | ||||||
MIRT640395 | ZNF785 | zinc finger protein 785 | ![]() |
![]() |
2 | 2 | ||||||
MIRT640505 | ANTXR1 | anthrax toxin receptor 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT641293 | SLAMF1 | signaling lymphocytic activation molecule family member 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT641863 | STOML1 | stomatin like 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT642600 | C14orf180 | chromosome 14 open reading frame 180 | ![]() |
![]() |
2 | 2 | ||||||
MIRT642895 | CASP1 | caspase 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT643967 | FHL2 | four and a half LIM domains 2 | ![]() |
![]() |
2 | 4 | ||||||
MIRT645237 | KCTD12 | potassium channel tetramerization domain containing 12 | ![]() |
![]() |
2 | 2 | ||||||
MIRT646621 | CENPL | centromere protein L | ![]() |
![]() |
2 | 2 | ||||||
MIRT648620 | CYB561A3 | cytochrome b561 family member A3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT648908 | ZNF551 | zinc finger protein 551 | ![]() |
![]() |
2 | 2 | ||||||
MIRT649439 | HIBADH | 3-hydroxyisobutyrate dehydrogenase | ![]() |
![]() |
2 | 2 | ||||||
MIRT650637 | LTF | lactotransferrin | ![]() |
![]() |
2 | 2 | ||||||
MIRT650971 | STARD3NL | STARD3 N-terminal like | ![]() |
![]() |
2 | 2 | ||||||
MIRT651067 | ZNF518B | zinc finger protein 518B | ![]() |
![]() |
2 | 4 | ||||||
MIRT652384 | TMEM55A | phosphatidylinositol-4,5-bisphosphate 4-phosphatase 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT653958 | SEPN1 | selenoprotein N | ![]() |
![]() |
2 | 2 | ||||||
MIRT656885 | KIF1C | kinesin family member 1C | ![]() |
![]() |
2 | 2 | ||||||
MIRT657965 | GAPVD1 | GTPase activating protein and VPS9 domains 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT658080 | FOXR2 | forkhead box R2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT662570 | IL2RA | interleukin 2 receptor subunit alpha | ![]() |
![]() |
2 | 2 | ||||||
MIRT663089 | METTL10 | EEF1A lysine methyltransferase 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT683705 | ZNF195 | zinc finger protein 195 | ![]() |
![]() |
2 | 2 | ||||||
MIRT683835 | ZNF682 | zinc finger protein 682 | ![]() |
![]() |
2 | 2 | ||||||
MIRT706811 | APOL4 | apolipoprotein L4 | ![]() |
![]() |
2 | 2 | ||||||
MIRT707575 | DYNC2LI1 | dynein cytoplasmic 2 light intermediate chain 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT708606 | ZNF260 | zinc finger protein 260 | ![]() |
![]() |
2 | 2 | ||||||
MIRT708859 | TMSB4X | thymosin beta 4, X-linked | ![]() |
![]() |
2 | 2 | ||||||
MIRT709861 | PDIK1L | PDLIM1 interacting kinase 1 like | ![]() |
![]() |
2 | 2 | ||||||
MIRT709987 | RBM41 | RNA binding motif protein 41 | ![]() |
![]() |
2 | 2 | ||||||
MIRT710098 | KPNA5 | karyopherin subunit alpha 5 | ![]() |
![]() |
2 | 2 | ||||||
MIRT710211 | ENAH | ENAH, actin regulator | ![]() |
![]() |
2 | 2 | ||||||
MIRT710868 | B3GALNT1 | beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group) | ![]() |
![]() |
2 | 2 | ||||||
MIRT710986 | SUSD5 | sushi domain containing 5 | ![]() |
![]() |
2 | 2 | ||||||
MIRT711460 | RNF145 | ring finger protein 145 | ![]() |
![]() |
2 | 2 | ||||||
MIRT712302 | PGM2L1 | phosphoglucomutase 2 like 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT713609 | SYTL4 | synaptotagmin like 4 | ![]() |
![]() |
2 | 2 | ||||||
MIRT713789 | MAK16 | MAK16 homolog | ![]() |
![]() |
2 | 2 | ||||||
MIRT715480 | MYO9B | myosin IXB | ![]() |
![]() |
2 | 2 | ||||||
MIRT716328 | POU5F1 | POU class 5 homeobox 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT717252 | TMEM246 | transmembrane protein 246 | ![]() |
![]() |
2 | 2 | ||||||
MIRT718077 | CLIC5 | chloride intracellular channel 5 | ![]() |
![]() |
2 | 2 | ||||||
MIRT718463 | EED | embryonic ectoderm development | ![]() |
![]() |
2 | 2 | ||||||
MIRT718645 | NKPD1 | NTPase KAP family P-loop domain containing 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT718982 | PIGO | phosphatidylinositol glycan anchor biosynthesis class O | ![]() |
![]() |
2 | 2 | ||||||
MIRT721078 | RPS9 | ribosomal protein S9 | ![]() |
![]() |
2 | 2 | ||||||
MIRT721419 | SEC24A | SEC24 homolog A, COPII coat complex component | ![]() |
![]() |
2 | 2 | ||||||
MIRT721863 | CENPJ | centromere protein J | ![]() |
![]() |
2 | 2 | ||||||
MIRT722492 | PNKD | paroxysmal nonkinesigenic dyskinesia | ![]() |
![]() |
2 | 2 | ||||||
MIRT723391 | CALN1 | calneuron 1 | ![]() |
![]() |
2 | 2 |
miRNA-Drug Associations | |||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|